Health & Life Co., Ltd.

1781 · TWO · Healthcare / Medical Devices

8.40TWD-0.06 (-0.71%)

Price History

Full chart

Market Stats

Previous Close8.46

Open8.50

Day Range8.23 – 8.50

52-Week Range9.82 – 14.50

Volume61.41K

Market Cap473.60M

P/E (TTM)0.00

Forward P/E0.00

EPS-1.07

Dividend Yield0.00%

Beta0.17

50-Day Avg10.66

200-Day Avg11.51

About

Health & Life Co., Ltd. manufactures and sells products for cardiovascular disease, in-vitro diagnostics, and respiratory care worldwide. It offers vibrating mesh nebulizers, blood pressure monitor products, IR thermometers, and hearing aid devices. The company was founded in 1996 and is based in New Taipei City, Taiwan.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Guo-He Yang
Employees0
HeadquartersNo. 186, Jian 1st Road, New Taipei City, Taiwan, 23553, Taiwan
Websitehttps://www.healthandlife.com.tw

Leadership

Mr. Guo-He YangChairman of the Board & CEO
Ms. Shu-Fen LiChief Accountant
Mr. Shao-Hong LiGM, Head of R&D and Director

Financials

Income Statement

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	811.88M	797.54M	601.17M	706.39M	398.05M
Growth (%)	-	-1.77%	-24.62%	+17.50%	-43.65%
Cost of Revenue	766.12M	699.82M	508.07M	558.65M	327.93M
Gross Profit	45.76M	97.72M	93.11M	147.74M	70.12M
Gross Margin	5.64%	12.25%	15.49%	20.91%	17.62%
Operating Expense	142.66M	142.81M	133.11M	145.24M	133.53M
Operating Income	-96.89M	-45.08M	-40.01M	2.50M	-63.41M
Operating Margin	-11.93%	-5.65%	-6.65%	0.35%	-15.93%
EBITDA	-	11.85M	-7.84M	55.63M	-46.70M
EBITDA Margin	-	1.49%	-1.30%	7.88%	-11.73%
Net Income	-62.34M	-17.55M	-33.23M	24.24M	-61.67M
Net Income Margin	-7.68%	-2.20%	-5.53%	3.43%	-15.49%
R&D	22.81M	17.34M	16.16M	18.35M	19.93M
R&D as % of Total Revenue	2.81%	2.17%	2.69%	2.60%	5.01%
Interest Expense	3.08M	3.14M	5.27M	3.38M	5.98M
Interest Expense % of Total Revenue	0.38%	0.39%	0.88%	0.48%	1.50%

Balance Sheet

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	776.39M	799.76M	710.79M	817.26M	723.13M
Total Liabilities	398.22M	427.18M	375.42M	424.21M	402.56M
Total Equity	378.18M	372.58M	335.37M	393.05M	320.57M
Cash	200.01M	156.64M	150.72M	227.02M	247.65M
Net Debt	-	4.24M	-	-	-

Cash Flow

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-131.15M	-80.69M	84.91M	33.39M	3.18M
Capital Expenditure	13.89M	12.32M	8.09M	2.85M	8.20M
Free Cash Flow	-145.04M	-93.02M	76.82M	30.54M	-5.01M
FCF to OCF	110.59%	115.27%	90.47%	91.47%	-157.38%

Earnings

Report Date	Oct 30, 2007	Apr 29, 2008	Oct 30, 2008	Apr 29, 2009	Aug 12, 2013
EPS Estimate	0.75	0.23	-0.24	-0.31	1.44
EPS Actual	0.48	0.54	0.08	-0.68	0.13
Surprise	-36.00%	134.78%	133.33%	-119.35%	-90.97%
Timing	Pre-market	Pre-market	Pre-market	Pre-market	After-hours

Key Statistics & Ratios

Market Cap473.60M

Enterprise Value452.06M

Trailing P/E0.00

Forward P/E0.00

Price / Sales1.18

Price / Book1.57

EPS-1.07

Book Value6.40

Revenue (TTM)400.09M

Gross Profit (TTM)54.88M

EBITDA-65.31M

Profit Margin-12.66%

Operating Margin-16.41%

Return on Equity-15.60%

Return on Assets-7.02%

Shares Outstanding47.41M

Shares Float35.43M

Beta0.17

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20141×

0.50Jul 25, 2014

20131×

0.10Sep 3, 2013